Prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis
Steffensen et al • 2016 • European Journal of Endocrinology
© 2024 Corcept Therapeutics, Incorporated
Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study
Costa et al • 2016 • J Diabetes Complications.
Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.
Vendruscolo et al. • 2015 • J Clin Invest. 2015;125(8):3193-7.
Association between mifepristone dose, efficacy, and tolerability in patients with Cushing syndrome.
Yuen et al. • 2015 • Endocr Pract. 2015;21(10):1087-92.
Mifepristone and Cushing syndrome: A commentary.
Kennedy L. • 2015 • Endocr Pract. 2015;21(10):1175-7.
Long-Term Follow-Up in Adrenal Incidentalomas: An Italian Multicenter Study
Morelli et al • 2014 • J Clin Endocrinol Metab.
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study
Di Dalmazi et al • 2014 • Lancet Diabetes Endocrinol.
Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas
Debono et al • 2014 • J Clin Endocrinol Metab.
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice.
Meyer et al. • 2014 • J Steroid Biochem Mol Biol. 2014 Sep;143:40-8.
Age- and sex-dependent effects of early life stress on hippocampal neurogenesis.
Loi et al. • 2014 • Front Endocrinol (Lausanne). 2014;5:13.